PT70064A - Process for preparing compounds with anti-inflammatory activity - Google Patents

Process for preparing compounds with anti-inflammatory activity

Info

Publication number
PT70064A
PT70064A PT70064A PT7006479A PT70064A PT 70064 A PT70064 A PT 70064A PT 70064 A PT70064 A PT 70064A PT 7006479 A PT7006479 A PT 7006479A PT 70064 A PT70064 A PT 70064A
Authority
PT
Portugal
Prior art keywords
inflammatory activity
preparing compounds
preparing
compounds
inflammatory
Prior art date
Application number
PT70064A
Other languages
English (en)
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of PT70064A publication Critical patent/PT70064A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT70064A 1978-08-15 1979-08-14 Process for preparing compounds with anti-inflammatory activity PT70064A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7833431 1978-08-15
GB7848348 1978-12-13

Publications (1)

Publication Number Publication Date
PT70064A true PT70064A (en) 1979-09-01

Family

ID=26268543

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70064A PT70064A (en) 1978-08-15 1979-08-14 Process for preparing compounds with anti-inflammatory activity

Country Status (9)

Country Link
US (1) US4296114A (pt)
EP (1) EP0008864A1 (pt)
AU (1) AU4985379A (pt)
DK (1) DK338379A (pt)
FI (1) FI792507A (pt)
GR (1) GR69706B (pt)
IL (1) IL58038A0 (pt)
NO (1) NO792653L (pt)
PT (1) PT70064A (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030795A3 (en) * 1979-12-06 1981-09-09 Imperial Chemical Industries Plc Quinoxaline derivatives, processes therefor, pharmaceutical compositions, and benzene derivatives
DE3032994A1 (de) * 1980-09-02 1982-04-22 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pyrazino-azepine, deren herstellung und diese sie enthaltende arzneimittel
JPS62198671A (ja) * 1986-02-25 1987-09-02 Toyo Jozo Co Ltd １−置換アルキル１，２−ジヒドロ−２−ピラジノン誘導体
JPS62281878A (ja) * 1986-02-26 1987-12-07 Taisho Pharmaceut Co Ltd アザアントラセン化合物
JPH0678319B2 (ja) * 1986-03-11 1994-10-05 東ソー株式会社 キノキサリノン誘導体
JPS6450868A (en) * 1987-08-21 1989-02-27 Toyo Jozo Kk 1-substituted alkyl-2-oxo-1,2-dihydroquinoxaline derivative
JPH0276860A (ja) * 1987-10-05 1990-03-16 Toyo Jozo Co Ltd ６−置換アルコキシ−２−オキソ−１，２−ジヒドロキノキサリン誘導体
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
GB9413975D0 (en) 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
WO1992011245A1 (en) * 1990-12-20 1992-07-09 Warner-Lambert Company 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
FR2696456B1 (fr) * 1992-10-07 1995-01-06 Pf Medicament Dérivés de dihydro-1,2 oxo amino-3 quinoxalines, leur préparation et leur application en thérapeutique.
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
JPH09510695A (ja) * 1994-01-03 1997-10-28 エイシア・ファーマシュウティカルズ，インコーポレイテッド ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用
GB2291422A (en) * 1994-07-18 1996-01-24 Fujisawa Pharmaceutical Co 4-phenyl-pyrido[2,3-b]pyrazin-4-ones
FR2731221B1 (fr) * 1995-03-01 1997-05-30 Pf Medicament Nouveaux derives de l'ethyl-1 dihydro-1, 2 oxo-2 methylamino-3 quinoxaline, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
GB9526558D0 (en) * 1995-12-27 1996-02-28 Fujisawa Pharmaceutical Co Heterobicyclic derivatives
ZA973884B (en) * 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
EP1380298A3 (en) * 1996-05-23 2004-04-07 Bristol-Myers Squibb Pharma Company Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders, anorexia, inflammation
US5869487A (en) * 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
US6087373A (en) * 1997-09-23 2000-07-11 Merck & Co., Inc. Thrombin inhibitors
CN1328555A (zh) * 1998-09-29 2001-12-26 藤泽药品工业株式会社 吡啶并吡嗪化合物的新的盐及其结晶
US6239132B1 (en) 1999-04-23 2001-05-29 Merck & Co., Inc. Thrombin inhibitors
JP2003501389A (ja) 1999-06-04 2003-01-14 メルク エンド カムパニー インコーポレーテッド トロンビン阻害物質
SK13752003A3 (en) * 2001-05-14 2004-11-03 Bristol Myers Squibb Pharma Co Substituted pyrazinones, pyridines and pyrimidines as ligands of factor releasing corticotropine
SE0302323D0 (sv) * 2003-08-28 2003-08-28 Astrazeneca Ab Novel compounds
SE0302324D0 (sv) * 2003-08-28 2003-08-28 Astrazeneca Ab Novel compounds
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
AU2004278372B2 (en) * 2003-09-30 2010-02-18 Janssen Pharmaceutica N.V. Quinoxaline compounds
WO2005042501A1 (en) * 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
ES2290782T3 (es) * 2004-01-06 2008-02-16 Janssen Pharmaceutica N.V. Derivados de (3-oxo-3,4-dihidro-quinoxalin-2-il-amino)-benzamida y compuestos aferentes como inhibidores de la glucogeno fosforilasa en el tratamiento de la diabetes y de la obesidad.
WO2006016278A1 (en) * 2004-08-09 2006-02-16 Warner-Lambert Company Llc Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
US7601716B2 (en) * 2006-05-01 2009-10-13 Cephalon, Inc. Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
DE102007050673A1 (de) 2007-10-19 2009-04-23 Friedrich-Schiller-Universität Jena Neue Hexaaza-acene und Verfahren zu ihrer Herstellung
TW200924770A (en) 2007-11-06 2009-06-16 Astrazeneca Ab Novel compounds 089
EP2250156B1 (en) * 2008-03-05 2015-05-06 Merck Patent GmbH Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
HUE033849T2 (en) * 2008-03-05 2018-01-29 Merck Patent Gmbh Pyridopyrazinone derivative for insulin secretagogues, methods for their preparation and their use in the treatment of diabetes
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
RU2532906C2 (ru) 2009-06-26 2014-11-20 Ихара Кемикал Индастри Ко., Лтд. Способ получения соединений, являющихся производными кетомалоновой кислоты, или их гидратов
MX2012003644A (es) 2009-10-02 2012-04-30 Astrazeneca Ab Compuestos de 2-piridona empleados como inhibidores de la elastasa neutrofila.
JP5921500B2 (ja) 2013-07-19 2016-05-24 イハラケミカル工業株式会社 ケトマロン酸化合物の製造方法
EP3109227B1 (en) 2014-02-17 2020-04-08 Kumiai Chemical Industry Co., Ltd. Method for continuously producing ketomalonic acid compound using flow reactor
US10604492B2 (en) 2015-12-24 2020-03-31 The Regents Of The Universtiy Of California CFTR regulators and methods of use thereof
EP3394046B1 (en) * 2015-12-24 2022-03-09 The Regents Of The University Of California Cftr regulators and methods of use thereof
CN111629730A (zh) 2017-08-24 2020-09-04 加利福尼亚大学董事会 眼部药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1189552B (de) * 1959-07-03 1965-03-25 Donau Pharmazie Ges M B H Verfahren zur Herstellung von 2-Oxo-1, 2-dihydrochinoxalinen und von deren Salzen und quaternaeren Ammoniumverbindungen
US4077955A (en) * 1977-02-17 1978-03-07 E. R. Squibb & Sons, Inc. Amino derivatives of 1,2,3,4-tetrahydro-2-oxopyrido[2,2-b]-pyrazine carboxylic acids and esters

Also Published As

Publication number Publication date
GR69706B (pt) 1982-07-09
FI792507A (fi) 1980-02-16
IL58038A0 (en) 1979-12-30
EP0008864A1 (en) 1980-03-19
DK338379A (da) 1980-02-16
US4296114A (en) 1981-10-20
NO792653L (no) 1980-02-18
AU4985379A (en) 1980-02-21

Similar Documents

Publication Publication Date Title
PT70064A (en) Process for preparing compounds with anti-inflammatory activity
YU42297B (en) Process for preparing new acylanilines
YU164379A (en) Process for preparing new urea compounds
YU42191B (en) Process for preparing 2-chloro-6-nitroanilines
GB2018816B (en) Process for preparing hexamethyltetrahydronaphthalenes
PT69686A (en) Process for preparing nitro compounds
PT70313A (en) Process for preparing substituted 1-thia-3-aza-4-ones
HU187258B (en) Process for preparing compopunds with hypotensive activity
YU36779A (en) Process for preparing new substituted 2-phenylimino-imidazolidines
PT69663A (en) Process for the preparation of new derivatives of 5-nitro-imidazole with antiprotozoic activity
DE2962639D1 (en) Process for preparing 2-chlorosulfinyl-azetidinones
PT69183A (en) Process for preparing novel n-azolylalkyl-halogenoacetanilides with herbicidal activity
GB2019835B (en) Process for preparing n-carbamoyl-d-thienylglycines
PT69687A (en) Process for preparing nitro compounds
DE2961058D1 (en) Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides
DE2960047D1 (en) Process for preparing 2-oximinophenylacetonitrile
YU41093B (en) Process for preparing 6-deoxy-5hydroxy-tetracycline
YU215279A (en) Process for preparing new alpha-alkyl-o-oxybenzylamines
GB2019367A (en) Catalytic process for so
YU40533B (en) Process for preparing 2-bromoergosinine
DE2964629D1 (en) Process for preparing 3-amino-5-t-butylisoxazole
PT69691A (en) Process for preparing n-tritylimidazole compounds
DE2963897D1 (en) Process for preparing sodium-m-nitrobenzenesulfonate
PT69287A (en) Process for preparing benzocycloheptapyrans
PH15975A (en) Process for preparing cis-bicyclooctylamines